Menu
  • Join
  • Login
  • Contact
 

Search abstracts


PREVALENCE OF THE CYP2C19 VARIANT *2 ALLELE IN MALTESE PATIENTS ON CLOPIDOGREL THERAPY

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: WIRTH, Francesca (UNIVERSITY OF MALTA, Pharmacy, Msida, Malta)
  • Co-author(s): Lilian M. Azzopardi
  • Abstract:

    The CYP2C19 loss-of-function (LoF) variant *2 allele is associated with attenuated response to clopidogrel which may lead to adverse cardiovascular outcomes post-percutaneous coronary intervention (PCI). To-date, prevalence of the *2 allele in the Maltese population has not been reported.

    Following ethics approval and informed written consent, 5mL

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses